GeneSoft Pharmaceuticals Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$169M
GeneSoft Pharmaceuticals General Information
Description
Provider of anti-infective pharmaceuticals. The company specializing in the discovery and development of a quinolone anti-infective product.
Contact Information
Corporate Office
- 7300 Shoreline Court
- South San Francisco, CA 94080
- United States
Corporate Office
- 7300 Shoreline Court
- South San Francisco, CA 94080
- United States
GeneSoft Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 06-Feb-2004 | $169M | Completed | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series D) | 14-May-2003 | Completed | Generating Revenue | |||
| 3. Grant | 18-Apr-2003 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series 1) | 12-Nov-2002 | $3M | $3M | Completed | Startup | |
| 1. Grant | 01-Jan-2002 | $15.3M | Completed | Startup |
GeneSoft Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 6,000,000 | $0.000100 | 8% | $2.5 | $2.5 | 1x | $2.5 | 16.86% |
| Series A | 5,425,000 | $0.000100 | 8% | $1 | $1 | 1x | $1 | 15.25% |
GeneSoft Pharmaceuticals Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LG Life Sciences (INDIA) | Corporation | Minority | ||
| MPM BioImpact | Venture Capital | Minority | ||
| Ultreia Capital | Venture Capital | Minority |
GeneSoft Pharmaceuticals FAQs
-
When was GeneSoft Pharmaceuticals founded?
GeneSoft Pharmaceuticals was founded in 1997.
-
Where is GeneSoft Pharmaceuticals headquartered?
GeneSoft Pharmaceuticals is headquartered in South San Francisco, CA.
-
What industry is GeneSoft Pharmaceuticals in?
GeneSoft Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is GeneSoft Pharmaceuticals a private or public company?
GeneSoft Pharmaceuticals is a Private company.
-
What is the current valuation of GeneSoft Pharmaceuticals?
The current valuation of GeneSoft Pharmaceuticals is .
-
What is GeneSoft Pharmaceuticals’s current revenue?
The current revenue for GeneSoft Pharmaceuticals is .
-
How much funding has GeneSoft Pharmaceuticals raised over time?
GeneSoft Pharmaceuticals has raised $40.3M.
-
Who are GeneSoft Pharmaceuticals’s investors?
LG Life Sciences (INDIA), MPM BioImpact, and Ultreia Capital have invested in GeneSoft Pharmaceuticals.
-
When was GeneSoft Pharmaceuticals acquired?
GeneSoft Pharmaceuticals was acquired on 06-Feb-2004.
-
Who acquired GeneSoft Pharmaceuticals?
GeneSoft Pharmaceuticals was acquired by Oscient Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
